Literature DB >> 21740420

Focal cortical dysplasia type IIb: completeness of cortical, not subcortical, resection is necessary for seizure freedom.

Jan Wagner1, Horst Urbach, Pitt Niehusmann, Marec von Lehe, Christian E Elger, Jörg Wellmer.   

Abstract

PURPOSE: Focal cortical dysplasia type IIb (FCD IIb) lesions are highly epileptogenic and frequently cause pharmacoresistant epilepsy. Complete surgical resection leads to seizure freedom in most cases. However, the term "complete" resection is controversial with regard to the necessity of performing resections of the subcortical zone, which is frequently seen in these lesions on magnetic resonance imaging (MRI).
METHODS: We retrospectively analyzed 50 epilepsy patients with histologically proven FCD IIb. The extent of surgical resection was determined by SPM5-based coregistration of the preoperative and postoperative MRI scans. Postoperative outcome was analyzed with regard to (1) the completeness of the resection of the cortical abnormality and (2) the completeness of the resection of the subcortical abnormality. KEY
FINDINGS: Complete resection of the cortical abnormality led to postoperative seizure freedom (Engel class Ia) in 34 of 37 patients (92%), whereas incomplete cortical resection achieved this in only one of 13 patients (8%, p < 0.001). Among the patients with complete cortical resection, 36 had FCDs with a subcortical hyperintensity according to MRI. In this group, complete resection of the subcortical abnormality did not result in a better postoperative outcome than incomplete resection (90% vs. 93% for Engel class Ia, n.s.). SIGNIFICANCE: Complete resection of the MRI-documented cortical abnormality in FCD IIb is crucial for a favorable postoperative outcome. However, resection of the subcortical hyperintense zone is not essential for seizure freedom. Therefore, sparing of the subcortical white matter may reduce the surgical risk of encroaching on relevant fiber tracts. In addition, these findings give an interesting insight into the epileptogenic propensity of different parts of these lesions. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 21740420     DOI: 10.1111/j.1528-1167.2011.03158.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  21 in total

1.  An intraoperative multimodal neurophysiologic approach to successful resection of precentral gyrus epileptogenic lesions.

Authors:  Mirela V Simon; Andrew J Cole; Eric C Chang; Bradley R Buchbinder; Steve M Stufflebeam; Ala Nozari; Anat O Stemmer-Rachamimov; Emad N Eskandar
Journal:  Epilepsia       Date:  2012-02-06       Impact factor: 5.864

2.  Bottom-of-Sulcus Dysplasia as an Epileptic Syndrome: The Power of Clinical Correlation.

Authors:  Barbara C Jobst
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

Review 3.  [Stereotactic laser thermocoagulation in epilepsy surgery].

Authors:  C Hoppe; J-A Witt; C Helmstaedter; T Gasser; H Vatter; C E Elger
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

4.  Spatial correlation of hemodynamic changes related to interictal epileptic discharges with electric and magnetic source imaging.

Authors:  Marcel Heers; Tanguy Hedrich; Dongmei An; François Dubeau; Jean Gotman; Christophe Grova; Eliane Kobayashi
Journal:  Hum Brain Mapp       Date:  2014-02-24       Impact factor: 5.038

5.  A longitudinal study of surgical outcome of pharmacoresistant epilepsy caused by focal cortical dysplasia.

Authors:  Bo Jin; Jing Wang; Jian Zhou; Shuang Wang; Yuguang Guan; Shuhua Chen
Journal:  J Neurol       Date:  2016-09-08       Impact factor: 4.849

6.  5-Aminolevulinic Acid-Induced Fluorescence in Focal Cortical Dysplasia: Report of 3 Cases.

Authors:  David W Roberts; Jaime J Bravo; Jonathan D Olson; William F Hickey; Brent T Harris; Lananh N Nguyen; Jennifer Hong; Linton T Evans; Xiaoyao Fan; Dennis Wirth; Brian C Wilson; Keith D Paulsen
Journal:  Oper Neurosurg (Hagerstown)       Date:  2019-04-01       Impact factor: 2.703

7.  Ultra-High-Field Targeted Imaging of Focal Cortical Dysplasia: The Intracortical Black Line Sign in Type IIb.

Authors:  E Bartolini; M Cosottini; M Costagli; C Barba; L Tassi; R Spreafico; R Garbelli; L Biagi; A Buccoliero; F Giordano; R Guerrini
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

8.  Predictors of seizure recurrence in patients with surgery for focal cortical dysplasia: pairwise and network meta-analysis and trial sequential analysis.

Authors:  Jie Chen; Xin Chen; Chen Huang; He Zhu; Zhi Hou; Ning An; Shi-Yong Liu; Hui Yang; Chun-Qing Zhang
Journal:  Childs Nerv Syst       Date:  2019-03-26       Impact factor: 1.475

Review 9.  Lesional cerebellar epilepsy: a review of the evidence.

Authors:  Niels A Foit; Vera van Velthoven; Reinhard Schulz; Ingmar Blümcke; Horst Urbach; Friedrich G Woermann; Christian G Bien
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

10.  Post-Surgical Outcome and Its Determining Factors in Patients Operated on With Focal Cortical Dysplasia Type II-A Retrospective Monocenter Study.

Authors:  Attila Rácz; Albert J Becker; Carlos M Quesada; Valeri Borger; Hartmut Vatter; Rainer Surges; Christian E Elger
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.